Comparative virulence of Haemophilus influenzae with a type b or type d capsule
- PMID: 6972914
- PMCID: PMC351477
- DOI: 10.1128/iai.32.2.518-524.1981
Comparative virulence of Haemophilus influenzae with a type b or type d capsule
Abstract
To determine the importance of specific capsule type in the pathogenesis of invasive Haemophilus influenzae disease, we compared the virulence of type b and type d strains isolated from different children with the virulence of transformation-derived type b and type d organisms. In addition, the unencapsulated derivative of these strains was also examined. Virulence was assessed by determining the ability of the strains to produce bacteremia with intranasal or subcutaneous inoculation. Unencapsulated derivatives were unable to cause bacteremia by any route; all type b strains (whether natural or derived by transformation), a natural type d, and a type d derived by transformation were able to produce bacteremia with similar frequency (42 to 62%) when 10(7) colony-forming units was given intranasally. Subcutaneous inoculation of 10(3) colony-forming units of strains with the type b capsule produced bacteremia at a greater frequency than did the strains with the type d capsule (P less than 0.002). The type d isolate was more virulent than a mutagenized derivative of the strain. We conclude that the type b strains are more virulent than type d when inoculated subcutaneously.
Similar articles
-
The type b capsular polysaccharide as a virulence determinant of Haemophilus influenzae: studies using clinical isolates and laboratory transformants.J Infect Dis. 1981 Apr;143(4):517-24. doi: 10.1093/infdis/143.4.517. J Infect Dis. 1981. PMID: 6972419
-
Effect of mutations in lipooligosaccharide biosynthesis genes on virulence of Haemophilus influenzae type b.Infect Immun. 1990 Jul;58(7):2343-51. doi: 10.1128/iai.58.7.2343-2351.1990. Infect Immun. 1990. PMID: 1694825 Free PMC article.
-
Contribution of lipopolysaccharide to pathogenicity of Haemophilus influenzae: comparative virulence of genetically-related strains in rats.Microb Pathog. 1986 Oct;1(5):465-73. doi: 10.1016/0882-4010(86)90008-2. Microb Pathog. 1986. PMID: 3509884
-
Molecular basis of invasive Haemophilus influenzae type b disease.J Infect Dis. 1992 Jun;165 Suppl 1:S77-81. doi: 10.1093/infdis/165-supplement_1-s77. J Infect Dis. 1992. PMID: 1588186 Review.
-
Type b capsular polysaccharide as a virulence factor of Haemophilus influenzae.Vaccine. 1988 Apr;6(2):113-5. doi: 10.1016/s0264-410x(88)80011-2. Vaccine. 1988. PMID: 3291448 Review.
Cited by
-
Cloning of a DNA fragment encoding a heme-repressible hemoglobin-binding outer membrane protein from Haemophilus influenzae.Infect Immun. 1996 Aug;64(8):3134-41. doi: 10.1128/iai.64.8.3134-3141.1996. Infect Immun. 1996. PMID: 8757844 Free PMC article.
-
Differential complement resistance mediates virulence of Haemophilus influenzae type b.Infect Immun. 1982 Jan;35(1):95-104. doi: 10.1128/iai.35.1.95-104.1982. Infect Immun. 1982. PMID: 6976328 Free PMC article.
-
Mutation frequency of Haemophilus influenzae to rifampin resistance.Antimicrob Agents Chemother. 1982 Sep;22(3):531-3. doi: 10.1128/AAC.22.3.531. Antimicrob Agents Chemother. 1982. PMID: 6982682 Free PMC article.
-
Experimental meningitis in the rat: Haemophilus influenzae.Infection. 1984;12 Suppl 1:S11-22. doi: 10.1007/BF01641734. Infection. 1984. PMID: 6397447 Review.
-
Molecular cloning and mechanism of trimethoprim resistance in Haemophilus influenzae.Antimicrob Agents Chemother. 1988 Apr;32(4):477-84. doi: 10.1128/AAC.32.4.477. Antimicrob Agents Chemother. 1988. PMID: 2837138 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources